NPPB and neuroendocrine neoplasm: Zuetenhorst et al. in 2004 dosed Cromogranin A (CgA), 5-Hydroxyindoleacetic acid (5-HIAA), ANP and NT-proBNP in 32 patients with neuroendocrine tumors.